Valerio Therapeutics Société anonyme (EPA:ALVIO)
France
· Delayed Price · Currency is EUR 0.137
-0.006 (-4.20%)
Mar 6, 2026, 4:56 PM CET
EPA:ALVIO Revenue
Valerio Therapeutics Société anonyme had revenue of 126.00K EUR in the half year ending June 30, 2025. This brings the company's revenue in the last twelve months to 1.83M, down -3.12% year-over-year. In the year 2024, Valerio Therapeutics Société anonyme had annual revenue of 1.79M, down -0.39%.
Revenue (ttm)
1.83M
Revenue Growth
-3.12%
P/S Ratio
38.20
Revenue / Employee
73.20K
Employees
25
Market Cap
69.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.79M | -7.00K | -0.39% |
| Dec 31, 2023 | 1.80M | 357.00K | 24.74% |
| Dec 31, 2022 | 1.44M | -2.62M | -64.48% |
| Dec 31, 2021 | 4.06M | 2.29M | 128.72% |
| Dec 31, 2020 | 1.78M | -2.51M | -58.59% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OSE Immunotherapeutics | 1.78M |
| Sensorion | 5.65M |
| ABIONYX Pharma | 4.33M |
| THX Pharma Société Anonyme | 876.13K |
| MaaT Pharma | 3.92M |
| Innate Pharma | 12.64M |
| Adocia | 12.88M |
| Fermentalg | 12.78M |